SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,827,729 | +78.7% | 1,508,416 | 0.0% | 0.40% | +73.2% |
| Q2 2023 | $8,296,288 | -11.3% | 1,508,416 | 0.0% | 0.23% | -32.5% |
| Q1 2023 | $9,352,179 | -59.3% | 1,508,416 | 0.0% | 0.34% | -64.8% |
| Q4 2022 | $23,003,344 | +54.5% | 1,508,416 | 0.0% | 0.97% | +57.9% |
| Q3 2022 | $14,888,000 | +88.5% | 1,508,416 | +126.3% | 0.62% | +61.0% |
| Q2 2022 | $7,900,000 | -37.6% | 666,666 | 0.0% | 0.38% | -24.7% |
| Q1 2022 | $12,667,000 | -18.8% | 666,666 | 0.0% | 0.51% | -10.4% |
| Q4 2021 | $15,600,000 | +8.2% | 666,666 | 0.0% | 0.57% | +0.7% |
| Q3 2021 | $14,413,000 | -15.3% | 666,666 | 0.0% | 0.56% | -11.8% |
| Q2 2021 | $17,007,000 | +7.5% | 666,666 | 0.0% | 0.64% | +7.4% |
| Q1 2021 | $15,820,000 | – | 666,666 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,104,875 | $21,122,000 | 6.34% |
| Aquilo Capital Management, LLC | 1,263,125 | $12,675,000 | 4.57% |
| Lombard Odier Asset Management (Europe) Ltd | 3,219,400 | $32,307,000 | 1.68% |
| Lombard Odier Asset Management (USA) Corp | 3,896,595 | $35,721,000 | 1.04% |
| Deep Track Capital, LP | 1,951,580 | $19,584,000 | 0.90% |
| Frazier Life Sciences Management, L.P. | 881,173 | $8,697,000 | 0.67% |
| BVF INC/IL | 1,508,416 | $14,888,000 | 0.62% |
| Parkman Healthcare Partners LLC | 127,458 | $1,279,000 | 0.36% |
| GREAT POINT PARTNERS LLC | 68,915 | $692,000 | 0.17% |
| CANTOR FITZGERALD, L. P. | 209,886 | $2,106,000 | 0.05% |